30
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      1230. Estimating Effective Point-of-Use Biocide Levels for Legionella Control in Building Water Systems Using a Large, Real-World Dataset

      abstract
      , MD 1 , , MD, MS 2 , , PhD, MPH 3 , , MD, MPH 4
      Open Forum Infectious Diseases
      Oxford University Press

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Legionnaires’ disease is a potentially life-threatening illness often associated with Legionella growth in water sources. Oxidizing biocides, such as chlorine (CL), monochloramine (MC) and chlorine dioxide (CD), can reduce Legionella contamination. However, limited guidance exists regarding optimal target biocide levels in building water systems to prevent Legionella growth. We examined Legionella and biocide data collected by Department of Veterans Affairs medical facilities nationally to estimate effective biocide levels.

          Methods

          Water samples collected at point of use for routine surveillance purposes between 2015 and 2017 were used for this analysis. Samples were limited to those with reported biocide being CL, MC or CD. Samples with biocide levels above safe drinking water maximums and from nonpotable water sources were excluded. Samples were stratified by hot and cold water and univariate logistic generalized additive models were used to assess nonlinear associations of probability of Legionella positivity and biocide level.

          Results

          The dataset included 144,458 samples (cold: 72,674; hot: 71,784) from 789 buildings at 168 hospitals, with 99,419 samples with reported biocide as CL, 40,922 as MC, and 4,117 as CD. For CL, cold water analysis showed a minimum probability of positivity at approximately 0.5 parts per million (ppm), but with a second minimum at 2 ppm. Hot water showed an inflection point around 0.6 ppm, but the likelihood of positivity continued to decrease until plateauing beyond 2 ppm (Figure 1). Cold water with MC showed a minimum probability of positivity at 0.3 ppm followed by a second minimum at 1.7 ppm with plateau beyond that concentration. Hot water showed a similar graph with initial minimum at 0.25 ppm and a second minimum at 1.6 ppm (Figure 2). CD graphs for both hot and cold showed a decrease at 0.2 ppm (Figure 3).

          Conclusion

          The variability in the dynamics of Legionella inhibition by different biocides as seen in our analysis indicates minimum biocide targets for the different agents. For CL and MC, biocide levels >2 ppm at point of use in building water systems may not provide added benefit for suppression of Legionella.

          Disclosures

          All authors: No reported disclosures.

          Related collections

          Author and article information

          Journal
          Open Forum Infect Dis
          Open Forum Infect Dis
          ofid
          Open Forum Infectious Diseases
          Oxford University Press (US )
          2328-8957
          October 2019
          23 October 2019
          23 October 2019
          : 6
          : Suppl 2 , IDWeek 2019 Abstracts
          : S442-S443
          Affiliations
          [1 ] VA Pittsburgh Healthcare System , Pittsburgh, Pennsylvania
          [2 ] University of Iowa Carver College of Medicine and Iowa City VA Health Care System , Iowa City, Iowa
          [3 ] National Infectious Diseases Service, Department of Veterans Affairs, Washington, DC; University of Cincinnati College of Medicine , Cincinnati, Ohio, Cincinnati, Ohio
          [4 ] National Infectious Diseases Service, Department of Veterans Affairs, Washington, DC; Cincinnati VA Medical Center, Cincinnati, OH; University of Cincinnati College of Medicine , Cincinnati, Ohio, Cincinnati, Ohio
          Article
          ofz360.1093
          10.1093/ofid/ofz360.1093
          6808913
          15a0aa4d-9899-42c1-86ff-c4c6587f97d2
          © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America.

          This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence ( http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com

          History
          Page count
          Pages: 2
          Categories
          Abstracts
          Poster Abstracts

          Comments

          Comment on this article

          scite_
          0
          0
          0
          0
          Smart Citations
          0
          0
          0
          0
          Citing PublicationsSupportingMentioningContrasting
          View Citations

          See how this article has been cited at scite.ai

          scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

          Similar content754